News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Aduro Clean Technologies advances HCT validation and commercial partnerships, prompting a catalysts-driven swing trade to $18.50 from $14.26.
  • ADUR trade plan: buy at $14.26, target $18.50, stop $12.50, with near-term test and FOAK logistics catalysts.
  • Analysts flag execution, regulatory and dilution risks for ADUR that could derail the catalysts-led rally.
  • Applied Industrial shows resilient fundamentals and cash generation but trades near 52-week highs on a stretched PE around 31.
  • Recommendation for Applied Industrial is to wait for a measured pullback before buying to avoid overhead risk.
  • Catalyst-focused small-cap trades look attractive, but stretched valuations increase risk of broader pullbacks for risk assets.

Latest Articles

FTSE 100 ticks up as oil spikes after US strikes on Iranian targets

FTSE 100 ticks up as oil spikes after US strikes on Iranian targets

British equities logged a modest gain on Monday as rising oil prices, driven by renewed US strikes against Iranian targets, buoyed energy-heavy names and helped the FTSE 100 eke out a positive close despite broader risk-off sentiment. European peers were mixed, sterling weakened, and safe-haven gold prices slipped while crude benchmarks climbed on …

PageGroup shares jump as Q2 update shows revenue declines stabilising

PageGroup shares jump as Q2 update shows revenue declines stabilising

PageGroup PLC shares rose sharply after the specialist recruiter released a Q2 2026 trading update before the London open that showed a near-flat group gross profit, sustained full-year guidance and improving gross profit per fee earner. The combination of stabilising topline trends across key regions, productivity gains and a supportive market bac…

GSK’s Jemperli Meets Primary Endpoint in Mid-Stage Rectal Cancer Study

GSK’s Jemperli Meets Primary Endpoint in Mid-Stage Rectal Cancer Study

GSK reported that Jemperli (dostarlimab) met the main endpoint in a phase II trial for a subset of locally advanced rectal cancer characterized by deficient DNA damage repair. Interim results indicate a clinically meaningful proportion of patients were free of detectable disease for at least one year, and safety findings matched earlier solid-tumor…

Stellantis Q2 Shipments Climb 10% Led by Strong North American Demand

Stellantis Q2 Shipments Climb 10% Led by Strong North American Demand

Stellantis reported preliminary second-quarter vehicle shipments up 10% year-on-year to almost 1.6 million units, propelled by a 38% jump in North America and a 5% rise in its Enlarged Europe market. The company said the North American increase reflected refreshed and new models and preparations for a planned summer production shutdown. Lower volum…

Stellantis Q2 vehicle shipments climb 10% as North America leads gains

Stellantis Q2 vehicle shipments climb 10% as North America leads gains

Stellantis reported preliminary second-quarter vehicle shipments rose 10% year-on-year to nearly 1.6 million units. The increase was concentrated in North America, where deliveries jumped 38% to 445,000 units, supported by a suite of new and refreshed models. Other regions showed more varied performance, with Enlarged Europe up modestly, while Midd…

European equities retreat as Middle East tensions lift oil prices

European equities retreat as Middle East tensions lift oil prices

European markets fell on Monday as renewed hostilities in the Middle East prompted investors to reduce exposure to risk assets. Iran’s Revolutionary Guards said the Strait of Hormuz was closed 'until further notice' after an attack on a commercial vessel and subsequent U.S. retaliatory strikes. Major indexes lost ground while oil and large oil prod…

Kongsberg Gruppen Shares Slide After Q2 2026 Results and Analyst Downgrade

Kongsberg Gruppen Shares Slide After Q2 2026 Results and Analyst Downgrade

Kongsberg Gruppen stock fell nearly 6% as the company released second-quarter 2026 results on a day when analysts were already forecasting a marked year-on-year decline in both earnings and revenue. Consensus estimates anticipated EPS of about 1.61 NOK, down from 1.85 NOK a year earlier, and revenue of roughly 10.06 billion NOK, a contraction of ar…

Tokyo shares slip as Nikkei retreats 1.76% amid sector weakness

Tokyo shares slip as Nikkei retreats 1.76% amid sector weakness

Tokyo's benchmark fell at Monday's close, with losses concentrated in Paper & Pulp, Transport and Communication sectors. The Nikkei 225 declined 1.76% as a larger number of issues fell than rose. Individual movers included Ryohin Keikaku surging to a record high while several technology and industrial names posted steep losses. Option-implied volat…

Sam Neill, Acclaimed Actor Known for Jurassic Park, Dies at 78

Sam Neill, Acclaimed Actor Known for Jurassic Park, Dies at 78

Sam Neill, the New Zealand-born actor whose career spanned more than 50 films and included his iconic turn as paleontologist Dr Alan Grant in Jurassic Park, has died at age 78. His family said the death in Sydney was "sudden and unexpected but blessed by the fact that Sam remained cancer free." Neill had announced in April that he was cancer free a…

BTIG Picks ServiceTitan as Its Leading SMID-Cap Investment Bet

BTIG Picks ServiceTitan as Its Leading SMID-Cap Investment Bet

BTIG has designated ServiceTitan Inc. (TTAN) as its top small- and mid-cap stock pick, citing the company’s AI initiatives—primarily its Virtual Agents product and Max program—and a valuation based on roughly 9 times enterprise value to calendar-year 2027 estimated sales. BTIG details revenue projections for fiscal years 2027 and 2028 and estimates…

ME Group Maintains Full-Year Guidance After Trading Recovers from April Dip

ME Group Maintains Full-Year Guidance After Trading Recovers from April Dip

ME Group International Plc has reaffirmed its full-year profit before tax guidance of £69 million to £74 million after trading improved following a sharp slowdown in April. Group revenue edged up 0.3% to £154.3 million for the six months ended April 30, 2026, while EBITDA increased to £57.0 million from £53.2 million a year earlier. The board descr…

Concurrent Technologies posts record H1 2026 revenue and pretax profit

Concurrent Technologies posts record H1 2026 revenue and pretax profit

Concurrent Technologies reported record first-half 2026 results, with revenue of £23.10 million and pretax profit of £3.30 million. Order intake for the period rose to £46.90 million, more than double the prior-year comparable, driven by demand across key regions and markets and bolstered by a large European contract. The company enters the second …

ME Group posts marginal H1 revenue gain as unit mix shifts

ME Group posts marginal H1 revenue gain as unit mix shifts

ME Group reported a 0.3% year-on-year increase in first-half revenue to 3154.3 million, driven by stronger laundry vending performance. Diluted earnings per share and profit before tax both fell modestly, and the company signalled full-year profit guidance and installation targets for 2026 while noting uneven demand across its businesses.

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Alamar Biosciences partners with leading US research universities and organizations to profile approximately 21,000 plasma samples from 10,000 Alzheimer’s Disease and Related Dementias participants using its NULISAseq Neuro 220 panel. This large-scale proteomics initiative aims to accelerate biomarker discovery and validation, creating an open-acce…